GlobalIPNews

Sign Up
|
Login
|

21:28:13 Mon 30 Mar 2026

Home
About Us
Industry
Assignee
Country
Support
Products
Services
View ALl

News For Last 1 Week

Industry

X

Assignee

X

Tianjin University

(42)

Shanghai Jiao Tong Univer

(31)

Regeneron Pharmaceuticals

(11)

China Pharmaceutical Univ

(9)

Tianjin University of Tec

(9)

Zhejiang University

(9)

Boehringer Ingelheim Inte

(7)

(6)

Jiangsu Hengrui Pharmaceu

(6)

(5)

Beijing Subenyuanhe Biote

(5)

Chia Tai Tianqing Pharmac

(5)

Eli Lilly and Company

(5)

Hebei Chemical & Pharmace

(5)

Lunan Pharmaceutical Grou

(5)

(5)

Shanghai University of Tr

(5)

Shenyang Pharmaceutical U

(5)

(4)

Gilead Sciences

(4)

Guangxi Zhuang Autonomous

(4)

Hoffmann La Roche

(4)

Kangmei Pharmaceutical

(4)

Lanzhou Institute Husband

(4)

Meilan Hangzhou Pharmaceu

(4)

Montara Therapeutics Inc

(4)

Qidong Dongsheng Pharmace

(4)

Ruijin Hospital Shanghai

(4)

(4)

Shenzhen Salubris Pharmac

(4)

Sichuan Kelun Botai Biome

(4)

State Grid Shanghai Munic

(4)

Tianjin University of Com

(4)

Tianjin University of Tra

(4)

Zhejiang Ausun Pharmaceut

(4)

Beijing Puqi Pharmaceutic

(3)

Beijing Tide Pharmaceutic

(3)

China Resources Sanjiu Me

(3)

Chongqing Shenghuaxi Phar

(3)

Daewoong Pharmaceutical

(3)

Genentech Inc [us]; Hoffm

(3)

Guangdong Pharmaceutical

(3)

Guangzhou Baiji Shenzhou

(3)

Haisco Pharmaceutical Gro

(3)

Jinghua Pharmaceutical Gr

(3)

Lianyungang Wantai Pharma

(3)

Lingke Pharmaceutical Han

(3)

Merck Sharp & Dohme

(3)

Mirati Therapeutics

(3)

Nanfang Hospital

(3)

Nanjing Zaiming Pharmaceu

(3)

Nantong University

(3)

(3)

(3)

Sanofi-Aventis Deutschlan

(3)

Shijiazhuang No 4 Pharmac

(3)

Sun Yat-sen University

(3)

Tianjin University of Sci

(3)

Tibet University

(3)

Wuhan Xirui Pharmaceutica

(3)

Wuxi Shenrui Bio Pharmace

(3)

Zhengzhou University

(3)

A2 Biotherapeutics

(2)

(2)

Accure Therapeutics S L

(2)

Adjutec Pharma As

(2)

Aferos Pharmaceuticals In

(2)

Affiliated Hospital of Qi

(2)

Affiliated Hospital of Sh

(2)

Aite Shenbo Suzhou Pharma

(2)

(2)

Anhui Xingzhou Pharmaceut

(2)

Beijing Chest Hospital Ca

(2)

Beijing Konruns Pharmaceu

(2)

Beijing Lande Wanbang Pha

(2)

Beijing University of Chi

(2)

Beijing Xuanjingrui Pharm

(2)

Beijing Zhongke Lihua Pha

(2)

Capital University of Med

(2)

Central South University

(2)

(2)

Chengdu Brilliant Pharmac

(2)

Chengdu Honray Technology

(2)

Chengdu Mfs Pharma Co Ltd

(2)

China Japan Friendship Ho

(2)

Chongqing Hilan Pharmaceu

(2)

Chongqing Peidu Pharmaceu

(2)

(2)

Curome Biosciences Co Ltd

(2)

Douglas Pharmaceuticals

(2)

Experimental Res Center C

(2)

First Affiliated Hospital

(2)

Flow Neuroscience Inc

(2)

(2)

Guangdong Hospital of Tra

(2)

Guangdong Jishibaicao Pha

(2)

Guangdong Zhongsheng Phar

(2)

Guilin Medical University

(2)

Hanghzou Bio Sincerity Ph

(2)

Heilongjiang University o

(2)

Hubei Shuangxing Pharmace

(2)

Hunan Jingcheng Pharmaceu

(2)

Hunan Jiudian Pharmaceuti

(2)

Institute Military Medici

(2)

JW Pharmaceutical

(2)

Jiangsu Hengrui Medicine

(2)

Jiangsu Huanghe Pharmaceu

(2)

Jiangsu Kanion Pharmaceut

(2)

Jiangsu Ocean University

(2)

Jiangsu Province Hospital

(2)

Jiangsu Yahong Meditech C

(2)

Jiangsu Yungou Pharmaceut

(2)

Jiangxi University of Tra

(2)

Jilin University

(2)

Kanglong Huacheng Ningbo

(2)

Kunming University of Sci

(2)

LaNova Medicines

(2)

Lantern Pharma Inc

(2)

Lenovo (Beijing) Limited;

(2)

Lisata Therapeutics Inc

(2)

Longhu Modern Immunology

(2)

Max Planck Gesellschaft

(2)

My T Bio Ltd [gb]; Cancer

(2)

Nanjing Dichang Pharmaceu

(2)

Nanjing University of Chi

(2)

(2)

(2)

Northwest Normal Universi

(2)

OMRON Tateisi Electronics

(2)

PLA Air Force Medical Uni

(2)

(2)

Pharmantera Inc

(2)

Provincial Hospital Affil

(2)

Purdue Research Foundatio

(2)

Qingdao Central Hospital

(2)

Qingdao Huashang Xinyao P

(2)

Quanta Therapeutics

(2)

Renji Hospital Shanghai J

(2)

Ribocure Pharmaceuticals

(2)

Rna Therapeutics Inc

(2)

Shaanxi Panlong Pharmaceu

(2)

Shandong University of Tr

(2)

Shandong University; Shan

(2)

Shandong Zibo Xincat Phar

(2)

Shanghai Beitong Pharmace

(2)

Shanghai Henlius Biotech

(2)

Shanghai Institute Of Pha

(2)

Shanghai Institute of Mat

(2)

Shanghai Investigation De

(2)

Shanghai Jiao Tong Univer

(2)

Shanghai Jiao Tong Univer

(2)

Shanghai Tobacco Group; S

(2)

Shenzhen Traditional Chin

(2)

Shouyao Holdings Beijing

(2)

Sichuan Huili Ind Co Ltd

(2)

Sichuan University

(2)

Simcere Pharmaceutical Co

(2)

Sirio Pharma Co Ltd

(2)

State Grid Shanghai Munic

(2)

Takeda Pharmaceuticals

(2)

Tekang Pharmaceutical Gro

(2)

The Regents of The Univer

(2)

Tianjin University; Weiha

(2)

United Therapeutics

(2)

University of Dundee

(2)

Veradermics Incorporated

(2)

Waterstone Pharmaceutical

(2)

West China 2nd University

(2)

West China Hospital, Sich

(2)

Wuhan Biopharmaceutical C

(2)

Wyvern Pharmaceuticals

(2)

Xi\'an Jiaotong Universit

(2)

Xiamen Kangji Biotechnolo

(2)

Xiangya Hospital Central

(2)

Xinhua Hospital affiliate

(2)

Xuzhou Bairui Mazui Tech

(2)

Yale University

(2)

Yangtze River Delta Medic

(2)

Yunnan Sanjiang Bencao Ph

(2)

Yunnan Shengke Pharmaceut

(2)

Yunnan Yousheng Pharmaceu

(2)

Zhejiang Anglikang Jinhe

(2)

Zhejiang Hisun Pharmaceut

(2)

Zhejiang Shengbang Biopha

(2)

Zunyi Medical University

(2)

4teen4 Pharmaceuticals Gm

(1)

(1)

ASM International Holding

(1)

Abion Inc [kr]; Seoul Nat

(1)

Abrexa Pharmaceuticals In

(1)

Acceleron Pharma

(1)

Accutar Biotechnology Inc

(1)

Acousia Therapeutics Gmbh

(1)

(1)

Actuate Therapeutics Inc

(1)

Acurx Pharmaceuticals Inc

(1)

(1)

(1)

Adv Med Solutions Ltd

(1)

Advanced Rna Vaccine Arv

(1)

(1)

Aelis Farma [fr]; Univ De

(1)

Aerorx Therapeutics Inc

(1)

Aether Therapeutics Inc

(1)

Affiliated Hospital of Qi

(1)

Affiliated Hospital of Sh

(1)

Affiliated Hospital of So

(1)

Affiliated Hospital of Ya

(1)

Agios Pharmaceuticals

(1)

Agnes Medical Co Ltd

(1)

Aiqiji Creation

(1)

Ajax Therapeutics

(1)

Ajou University Industry-

(1)

Akande Janet Mubo [us]; A

(1)

Albert Einstein College o

(1)

Aleksia Therapeutics Inc

(1)

(1)

(1)

Allergan Pharmaceuticals

(1)

(1)

Ambati Jayakrishna [us];

(1)

Amicus Therapeutics

(1)

Angootioshnari Farshid

(1)

Anhui Boyao Qiancao Tradi

(1)

Anhui Changjiang Pharmace

(1)

Anhui Guixin Linyan Pharm

(1)

Anhui Huajun Pharmaceutic

(1)

Anhui Huanqiu Pharmaceuti

(1)

Anhui Huazhi Biological P

(1)

Anhui Jiuxin Pharmaceutic

(1)

Anhui Jiuzhou Fangyuan Ph

(1)

Anhui Keyun Baicao Pharma

(1)

Anhui Medical University

(1)

Anhui Shennong Baicao Pha

(1)

Anhui Tianan Biotechnolog

(1)

Anhui University

(1)

Anhui Xintai Pharmaceutic

(1)

Annexin Pharmaceuticals A

(1)

(1)

(1)

(1)

Anya Pharmaceuticals Inc;

(1)

Anyuan Medicine Tech Shan

(1)

Apeximmune Therapeutics I

(1)

Apharm Health Co Ltd

(1)

Aphea Bio Nv [be]; Fundac

(1)

Apinovo Pharma Innovation

(1)

Apnimed Inc Delaware [us]

(1)

Arctic Therapeutics Hf

(1)

Arizona Board Of Regents

(1)

Arlucky Antibody Therapeu

(1)

Asap Breatheassist Pty Lt

(1)

Assembly Biosciences

(1)

Astellas Pharma

(1)

(1)

AstraZeneca Sweden AB

(1)

Astrizi Bio Inc

(1)

(1)

Aug Winkhaus Se

(1)

(1)

Avantgen Inc [us]; The Tr

(1)

Azurity Pharmaceuticals I

(1)

Bactopharma Gmbh

(1)

Baicheng Medical College

(1)

Bailing Yuxiu Zhuhai Phar

(1)

Baoding Jizhong Pharmaceu

(1)

Baoding Tianhao Pharmaceu

(1)

Baoheng Pharmaceutical Be

(1)

Baowu Special Metallurgy;

(1)

(1)

Bawang Guangzhou Co Ltd

(1)

(1)

Becton Dickinson

(1)

Beihua University

(1)

Beijing Anding Hospital,C

(1)

Beijing Baofutang Inst Of

(1)

Beijing Fuyuan Pharmaceut

(1)

Beijing Healstec Pharmace

(1)

Beijing Jincheng Taier Ph

(1)

Beijing Medical Plasma La

(1)

Beijing Medkon Pharmaceut

(1)

Beijing Meikangtang Pharm

(1)

Beijing Niuambo Biotechno

(1)

Beijing Paite Boen Biotec

(1)

Beijing Pinzhao Pharmaceu

(1)

Beijing Renwei Pharmaceut

(1)

Beijing Rimeng Biological

(1)

Beijing Sanyou Likang Cel

(1)

Beijing Solarbio Technolo

(1)

Beijing Syngentech Co Ltd

(1)

Beijing Tri Prime Gene Ph

(1)

Beijing Tricision Biother

(1)

Beijing University

(1)

Beijing University of Chi

(1)

Beijing Yaoyun Data Tech

(1)

Beijing Youcare Kechuang

(1)

Beijing Yuanyan Pharmaceu

(1)

Beijing Yujing Pharmaceut

(1)

Belhaven Biopharma Inc

(1)

Bella Biomedica Inc

(1)

Bengbu Medical University

(1)

Beone Medicines I Gmbh

(1)

Bide Pharmatech Co Ltd

(1)

Big Health Res Institute

(1)

(1)

Biocomo Inc; Univ Mie

(1)

Biofire Diagnostics Llc [

(1)

(1)

(1)

Biontech Se [de]; Oncoc4

(1)

Biopharma Synergies S L

(1)

Bioray Pharmaceutical Han

(1)

Biscayne Neurotherapeutic

(1)

Bisirna Therapeutics Suzh

(1)

(1)

Bloomage BioTechnology

(1)

Bohui Biopharmaceutical C

(1)

(1)

Bozhi Anjian Hebei Pharma

(1)

Breakthrough Pharmaceutic

(1)

Bridge Medicines

(1)

Brigham & Women\'s Hospit

(1)

Bristol Myers Squibb

(1)

CHA University Industry A

(1)

CSPC Megalith Biopharmace

(1)

(1)

California Institute Of T

(1)

(1)

Caremedi Co Ltd [kr]; Sog

(1)

Cas Nanjing Inst Of Life

(1)

Cascade Pharmaceuticals I

(1)

Case Western Reserve Univ

(1)

Center For Excellence In

(1)

Centre Nat Rech Scient [f

(1)

Centrexion Therapeutics

(1)

Cerevel Therapeutics Llc

(1)

Changchun Inst Applied Ch

(1)

Changchun Lanjiang Pharma

(1)

Changde No 1 Traditional

(1)

Changji City Peoples Hosp

(1)

Changsha Huir Biological

(1)

Changsha Pingxin Pharmacy

(1)

Changwu Traditional Chine

(1)

Changyi Tianyu Pharmaceut

(1)

Changzhou University

(1)

Chengdu Anticancer Biosci

(1)

Chengdu Brilliant Pharmac

(1)

Chengdu Chipscreen Pharma

(1)

Chengdu Diao Jiuhong Phar

(1)

Chengdu Easton Biopharmac

(1)

Chengdu Jinshan Chemical

(1)

Chengdu Kanghong Pharmace

(1)

Chengdu Leer Pharmaceutic

(1)

Chengdu Real Pharmaceutic

(1)

Chengdu Sibeibo Pharmaceu

(1)

Chengdu Xinyuecheng Ind C

(1)

Chengdu Yangtian Wanying

(1)

Chengdu Yaoyi Likang Medi

(1)

Chengduaobang Medicine Co

(1)

Chiesi Farmaceutici

(1)

Children\'s Hospital of C

(1)

China Acad Of Chinese Med

(1)

China Resources Double Cr

(1)

Chong Kun Dang Pharmaceut

(1)

Chongqing Hongsheng Pharm

(1)

Chongqing Medical & Pharm

(1)

Chongqing Peg Bio Biotech

(1)

Chongqing Pujian Pharmace

(1)

Chongqing Ruien Medicine

(1)

Chongqing University of T

(1)

Chongqing Yaogu Pharmaceu

(1)

Chongqing Yuanlun Bio Tec

(1)

Chongqing Zhihe Bio Pharm

(1)

Chongqing Zuodianyou Comm

(1)

Chugai Pharmaceutical

(1)

Chumei Tech Hangzhou Co L

(1)

Church William R

(1)

Cidai Biosciences Inc

(1)

(1)

Circle Pharma Inc

(1)

Cisen Pharmaceutical Co L

(1)

Cithers Therapeutics Inc

(1)

Clapham Andrew John [us];

(1)

Climate Bridge Hunan Eco

(1)

Cls Therapeutics Ltd

(1)

Co Nstellation Pharmaceut

(1)

Colgate-Palmolive Company

(1)

Collaborations Pharmaceut

(1)

Columbia University

(1)

(1)

(1)

Corcept Therapeutics

(1)

Core Biotherapeutics Inc

(1)

Crinetics Pharmaceuticals

(1)

Css Pharma L L C

(1)

Cstone Pharmaceutical Suz

(1)

(1)

Cusabio Biotech Co Ltd

(1)

(1)

D&d Biopharmaceuticals Ll

(1)

Daewoong Pharmaceutical C

(1)

(1)

Dalian Institute of Chemi

(1)

Dalian University

(1)

Decibel Therapeutics Inc

(1)

Deciphera Pharmaceuticals

(1)

Decoy Therapeutics Inc

(1)

Delta Fly Pharma Inc

(1)

Denali Therapeutics

(1)

(1)

Dianshi Luoyang Intellige

(1)

Dompe Farm S P A

(1)

(1)

Dongguan Zhongke Cloud Co

(1)

Dongying Pingming Pharmac

(1)

(1)

Dren Bio Man Inc

(1)

Dyno Therapeutics

(1)

Eagle Pharmaceuticals

(1)

East China jiaoTong Unive

(1)

(1)

Electric Power Research I

(1)

Eleusis Therapeutics Us I

(1)

(1)

Emory University

(1)

Enb Therapeutics Inc

(1)

(1)

Enshi Enrong Pharmaceutic

(1)

Enveric Biosciences Canad

(1)

Epizon Pharma Inc

(1)

Equashield Medical

(1)

Equator Therapeutics Inc

(1)

Erchu of China Railway Tu

(1)

Etico Lifesciences Privat

(1)

Everest Medicines Singapo

(1)

Fanshi Hengyu Natural Her

(1)

Faron Pharmaceuticals Oy

(1)

Felicamed Biotechnology C

(1)

Fertinagro Biotech S L

(1)

Fertinagro Biotech Sl

(1)

Fine Washed Llc

(1)

Finn Therapeutics Gmbh

(1)

Firmenich & Cie

(1)

First People\'s Hospital

(1)

First Teaching Hospital,

(1)

(1)

Fluoguide As (fluoguide

(1)

Forage Inst Xinjiang Acad

(1)

Foresee Pharmaceuticals C

(1)

Foresite Labs Llc

(1)

Foshan Deruike Pharmaceut

(1)

Fudan University

(1)

Fujian Medical University

(1)

Fujian Ruitailai Pharmace

(1)

Fujian University of Trad

(1)

Fundacion Para El Fomento

(1)

Fuqing Huizhong Pharmacy

(1)

Fuzhou Fuqixiang Traditio

(1)

Fuzhou Medical Univ

(1)

Fuzhou Neptunus Jinxiang

(1)

Fuzhou Tongshantang Smart

(1)

GE Prec Healthcare

(1)

Gachon Univ Of Industry A

(1)

(1)

Galderma Holding

(1)

(1)

Gannan Medical University

(1)

Gannan Normal University

(1)

Gansu Fuxi Pharmaceutical

(1)

Gansu Qizheng Ind Group C

(1)

Gansu University of Chine

(1)

Gansu Zhizi Pharmaceutica

(1)

Gemvax & Kael Co Ltd

(1)

Gen Ilac Ve Saglik Urunle

(1)

Genentech Inc [us]; Newli

(1)

Genentech Inc [us]; Pfize

(1)

Genentech Inc [us]; Roche

(1)

Genentech; Broad Institut

(1)

Genentech; Hoffmann La Ro

(1)

Geneos Therapeutics Inc

(1)

General Hospital of Xuzho

(1)

(1)

Georgia Tech Research Cor

(1)

(1)

(1)

Glaxosmithkline Intellect

(1)

Glenmark Pharmaceuticals

(1)

Gmp Biotechnology Ltd [cn

(1)

Granules India Ltd

(1)

Granules Pharmaceuticals

(1)

(1)

Guangdong China Resources

(1)

Guangdong Dekang Traditio

(1)

Guangdong Deqing Wubiyang

(1)

Guangdong HEC Pharmaceuti

(1)

Guangdong Hospital of Tra

(1)

Guangdong Kang Rong Ind C

(1)

Guangdong Laboratory Of T

(1)

Guangdong Lecaoyuan Healt

(1)

Guangdong Second Traditio

(1)

Guangdong Weizheng Pharma

(1)

Guangdong Yifang Pharmace

(1)

Guangdong Zhongke Pharmac

(1)

Guangdong Zhongsheng Ruic

(1)

Guangdong Zijian Chuanghe

(1)

Guangtian Yingtai Shangha

(1)

Guangxi Power Grid Llc [c

(1)

Guangxi Strong Life Pharm

(1)

Guangxi Tairong Pharmaceu

(1)

Guangxi Therapeutic Medic

(1)

Guangxi University of Chi

(1)

Guangxi Zhuang Autonomous

(1)

Guangzhou Anbofu Automati

(1)

Guangzhou Anobri Pharmace

(1)

Guangzhou Baiyun Shan Min

(1)

Guangzhou Baiyunshan Qixi

(1)

Guangzhou Future Gene Del

(1)

Guangzhou Hanguang Pharma

(1)

Guangzhou Inst Of Biomedi

(1)

Guangzhou Institute of Te

(1)

Guangzhou Jieerke Biotech

(1)

Guangzhou Medical Univers

(1)

Guangzhou Minle Network T

(1)

Guangzhou National Labora

(1)

Guangzhou No 12 Peoples H

(1)

Guangzhou Saiensi Medical

(1)

Guangzhou Shouyang Pharma

(1)

Guangzhou Zhongtian Bio T

(1)

Guilin University of Elec

(1)

Guilin University of Tech

(1)

Guiyang Xin Tian Pharmace

(1)

Guizhou Alian Jiaqing Pro

(1)

Guizhou Bailing Group Pha

(1)

Guizhou Beiyinte Biotechn

(1)

Guizhou Dechangxiang Phar

(1)

Guizhou Guang Zheng Pharm

(1)

Guizhou Liangji Pharmaceu

(1)

Guizhou Shanyang Tech Co

(1)

Guizhou Tongde Pharmaceut

(1)

Guizhou Yibai Nvzi Large

(1)

Guoyaojituan Tongjitang G

(1)

Hainan Normal University

(1)

Hainan University

(1)

Hainan University; Sanya

(1)

Hainan Wekon Pharmaceutic

(1)

Hainan Yunze Pharmaceutic

(1)

(1)

Haltaif Pharma Ag

(1)

Hamlet Pharma Ab

(1)

Hanghzou Bio Sincerity Ph

(1)

Hangzhou Baotai Biotechno

(1)

Hangzhou Biogenome Biotec

(1)

Hangzhou Brown Bio Pharm

(1)

Hangzhou Center For Disea

(1)

Hangzhou Chengzhe Biomedi

(1)

Hangzhou Dandelion Life T

(1)

Hangzhou Gaoguang Pharmac

(1)

Hangzhou Huake Biotechnol

(1)

Hangzhou Innogate Pharma

(1)

Hangzhou Jitai Life Scien

(1)

Hangzhou Qianai Rentang T

(1)

Hangzhou Qunan Likang Bio

(1)

Hangzhou Sciwind Bioscien

(1)

Hangzhou Thinhay Pharma T

(1)

Hangzhou Third Peoples Ho

(1)

Hangzhou Xinchang Gene Th

(1)

(1)

Hanx Biopharmaceuticals W

(1)

Harbin Tianmei Pharmaceut

(1)

Harbin University of Scie

(1)

Harmony Biosciences Manag

(1)

(1)

Havah Therapeutics Pty Lt

(1)

(1)

Healios Therapeutics Llc

(1)

Health Decode Pharmacy Gu

(1)

Hebei Gucaotang Biologica

(1)

Hebei Junlin Pharmaceutic

(1)

Hebei Keyi Hospital Man C

(1)

Hebei Longhai Pharmaceuti

(1)

Hebei Runhua Pharmaceutic

(1)

Hebei Sanxin Pharmaceutic

(1)

Hebei Seventh People\'s H

(1)

Hebei Shengxue Dacheng Ph

(1)

Hebei University of Scien

(1)

Hebei Yuchen Pharmaceutic

(1)

Hebei Yunde Pharmaceutica

(1)

Heilongjiang Bayi Agricul

(1)

Heilongjiang Yuxuan Biolo

(1)

Helicore Biopharma Inc

(1)

Henan Agricultural Univer

(1)

Henan Dulitong Commerce A

(1)

Henan Huafeng Pharmacy Co

(1)

Henan Tiefu Medical Tech

(1)

Henan University of Chine

(1)

Henan University of Scien

(1)

Hezhou Zhongshan Suawin C

(1)

Hifas Da Terra S L

(1)

Hill Patricia [us]; Hill

(1)

Hoffmann La Roche Inc [us

(1)

Hr Pharmaceuticals Inc

(1)

Huahong Pharmaceutical Gr

(1)

Huamei Tech Group Co Ltd;

(1)

Huaneng Tongliao Wind Pow

(1)

Huanggang Humanwell Pharm

(1)

Huaqiao University

(1)

Huashan Hospital, Fudan U

(1)

Huawu Biomedical Tech Hub

(1)

Huaxian Hospital Of Xinxi

(1)

Huaxiashengsheng Pharmace

(1)

Huazhong Pharmaceutical C

(1)

Huazhong University of Sc

(1)

Huazhong University of Sc

(1)

Hubei Guangren Medicament

(1)

Hubei Jiangxia Laboratory

(1)

Hubei Kanghui Dongbao Pha

(1)

Hubei Luyu Dietotherapy M

(1)

Hubei Maternal and Child

(1)

Hubei Polytechnic Univers

(1)

Hubei Tianyi Health Res I

(1)

Hubei Xianglian Pharmaceu

(1)

Hubei Zaofu Pharmaceutica

(1)

Huida Shanghai Biotechnol

(1)

Huisheng Biological Pharm

(1)

Humanwell Healthcare Usa

(1)

Hunan Academy of Chinese

(1)

Hunan Huawu Xingchen Medi

(1)

Hunan Junxin Environmenta

(1)

Hunan Meibai Biological P

(1)

Hunan Norchem Pharmaceuti

(1)

Hunan Normal University

(1)

Hunan Nuosai Cell Applica

(1)

Hunan Province Xiangzhong

(1)

Hunan Sailong Pharmaceuti

(1)

Hunan Shentaichun Pharmac

(1)

Hunan University of Chine

(1)

Hunan World Well Being Bi

(1)

Hunan Zhenqing Pharmaceut

(1)

(1)

Huzhou Center For Disease

(1)

Huzhou Yase Pharmaceutica

(1)

I Mab Biopharma Us Ltd [u

(1)

IDEAYA Biosciences

(1)

Icon Therapeutics Inc

(1)

Imbria Pharmaceuticals

(1)

(1)

Immunecare Biopharmaceuti

(1)

(1)

(1)

Impact Therapeutics Inc;

(1)

Indivior Uk Ltd

(1)

Inner Mongolia Anzhou Pha

(1)

Inner Mongolia Huazhou Ph

(1)

Inner Mongolia Interntion

(1)

Inner Mongolia Mengqi Pha

(1)

Inner Mongolia Research I

(1)

Inner Mongolia Research I

(1)

Insilico Medicine

(1)

Inst Nat Sante Rech Med [

(1)

Inst Of Laboratory Animal

(1)

Inst Regional Cancer Mont

(1)

Institute Of Basic Res In

(1)

Institute Tropical Biosci

(1)

Institute of Applied Ecol

(1)

Institute of Biophysics,

(1)

Institute of Electrical E

(1)

Institute of Materia Medi

(1)

Institute of Medicinal Pl

(1)

Institute of Process Engi

(1)

Institute of Radiation Me

(1)

Institute of Zoology, Chi

(1)

Insulet Corporation

(1)

Intas Pharmaceuticals

(1)

(1)

Interdict Bio Inc

(1)

(1)

Iowa State University Res

(1)

(1)

(1)

Japan As Represented By D

(1)

Javelin Biotech Inc

(1)

Jiamusi Maternal And Chil

(1)

Jiamusi University

(1)

Jiangmen Aobao Biological

(1)

Jiangnan University

(1)

Jiangsu Allist Biological

(1)

Jiangsu Alpha Group Sheng

(1)

Jiangsu Alphamab Biopharm

(1)

Jiangsu Anbisheng Pharmac

(1)

Jiangsu Baju Pharmaceutic

(1)

Jiangsu Cancer Hospital

(1)

Jiangsu Coben Pharmaceuti

(1)

Jiangsu College of Nursin

(1)

Jiangsu Deyuan Pharmaceut

(1)

Jiangsu Eachy Biomedical

(1)

Jiangsu Food & Pharmaceut

(1)

Jiangsu Fubang Pharmaceut

(1)

Jiangsu Haiyao Pharmaceut

(1)

Jiangsu Hengrui Medicine;

(1)

Jiangsu Hengrui Medicine;

(1)

Jiangsu Hengrui Medicine;

(1)

Jiangsu Hengrui Medicine;

(1)

Jiangsu Houbang Ind Co Lt

(1)

Jiangsu Huagang Pharmaceu

(1)

Jiangsu Institute of Poul

(1)

Jiangsu Jiaerke Pharmaceu

(1)

Jiangsu Jinteng Pharmaceu

(1)

Jiangsu Jiyu Biomedical T

(1)

Jiangsu Lianhuan Pharmace

(1)

Jiangsu Maiweikang New Dr

(1)

Jiangsu Normal University

(1)

Jiangsu Province Hospital

(1)

Jiangsu Puxin Pharmaceuti

(1)

Jiangsu Trautec Medical T

(1)

Jiangsu Weiqida Pharmaceu

(1)

Jiangsu Weiyao Informatio

(1)

Jiangsu Xiwang Tianye Eco

(1)

Jiangsu Yabang Aipusen Ph

(1)

Jiangsu Yahong Medicine S

(1)

Jiangsu Yongchuang Pharma

(1)

Jiangxi Brother Pharmaceu

(1)

Jiangxi Guangenhe Pharmac

(1)

Jiangxi Pulier Pharmaceut

(1)

Jiangxi Rongxing Pharmace

(1)

Jiangxi University of Tra

(1)

Jiangxi Yibainian Pharmac

(1)

Jiangyin Tianjiang Pharma

(1)

Jianyidao Intelligent Tec

(1)

Jiaxing Heji Pharmaceutic

(1)

Jilin Changbaishan Pharma

(1)

Jilin Mufeng Pharmaceutic

(1)

Jilin Tianheng Pharmaceut

(1)

Jilin Zhenao Pharmaceutic

(1)

Jinan University

(1)

(1)

Jingshi Hangzhou Pharmace

(1)

Jingyin Pharmaceutical Co

(1)

Jinpai Chizhengtang Pharm

(1)

Jinyao Heping Tianjin Pha

(1)

Jisikai Suzhou Pharmaceut

(1)

Jitai Biotech Inc

(1)

Jiuzhou Pharmaceutical Ha

(1)

Jnana Therapeutics

(1)

Johns Hopkins University

(1)

Joincaring Co Ltd

(1)

Junhemeng Biopharmaceutic

(1)

Kamp Pharmaceutical

(1)

Kangbaida Sichuan Biomedi

(1)

Kangfang Huike Shanghai B

(1)

Kanglong Huacheng Chiral

(1)

Kangnuoya Biological Medi

(1)

Kangyuan Bochuang Bio Tec

(1)

Kawasaki Inst Of Industri

(1)

Keeps Biopharma Inc

(1)

Kergen Pharma Tech Co Ltd

(1)

Keto Innovations Llc

(1)

Kiniksa Pharmaceuticals

(1)

(1)

(1)

Korea Inst Of Oriental Me

(1)

Korea Institute Of Scienc

(1)

Korea Institute of Materi

(1)

Korea University Research

(1)

(1)

Kpc Pharmaceuticals Inc;

(1)

Kunming Institute of Bota

(1)

Kunming Medical Universit

(1)

Kunming University

(1)

Kunshan Jingwei New Mater

(1)

Kwizda Pharma Gmbh

(1)

Kyowa Pharma Chemical Co

(1)

(1)

(1)

Lantmaennen Medical Ab

(1)

(1)

Laveloc Therapeutics Llc

(1)

Le Roux Danielle Marie [u

(1)

Lean Inc; Guizhou Leen Bi

(1)

Legacy Healthcare (Switze

(1)

Leiutis Pharmaceuticals L

(1)

Leland Stanford Junior Un

(1)

Lepu Pharmaceutical Co Lt

(1)

Les Laboratoires Servier

(1)

Leti Pharma S L

(1)

(1)

(1)

(1)

(1)

Liaoning Heming Pharmaceu

(1)

Life No 1 Pharmaceutical

(1)

Lingyi Artificial Intelli

(1)

Liuren Hangzhou Medical T

(1)

Liuzhou Haida New Materia

(1)

Longbio Pharma Suzhou Co

(1)

Longgang District People\

(1)

Longhu Modern Immunology

(1)

Longshunrong Pharmaceutic

(1)

Luqingge Gansu Pharmaceut

(1)

Luwei Pharmaceutical Grou

(1)

Luye Jiaao Pharmaceutical

(1)

(1)

Macau Univ Of Science And

(1)

Macro Biologics Inc

(1)

Maggscience S R L

(1)

Maidi Kexin Shenyang Biot

(1)

Marshall Univ Research Co

(1)

Mat Engineering And Techn

(1)

Mediengine Co Ltd; Korea

(1)

Medpacto Inc [kr]; Bae Il

(1)

(1)

Meiya Pharmaceutical Haia

(1)

Mg Stroke Analytics Inc

(1)

(1)

Microvascular Therapeutic

(1)

Mirum Pharmaceuticals

(1)

Mitsubishi Gas Chemical C

(1)

Moebius Medical Ltd

(1)

Monash University

(1)

Mslt Hangzhou Biotechnolo

(1)

(1)

Mycotech Pharma As

(1)

Nacuity Pharmaceuticals I

(1)

Nafei (Shenzhen) Pharmace

(1)

Nanchang Atomic High Tech

(1)

Nanfang Hospital, Souther

(1)

Nanjing Dichang Pharmaceu

(1)

Nanjing Easeheal Pharmace

(1)

Nanjing H&d Pharmaceutica

(1)

Nanjing Hospital of Tradi

(1)

Nanjing Housheng Pharmace

(1)

Nanjing Huabeikang Medica

(1)

Nanjing Huili Biotechnolo

(1)

Nanjing Laisi Wangxin Tec

(1)

Nanjing Langbote Animal P

(1)

Nanjing Meishan Hospital;

(1)

Nanjing Tianyin Jianhua P

(1)

Nanjing Univ Of Chinese M

(1)

Nanjing Vocational Instit

(1)

Nanjing Xietong Renewable

(1)

Nanjing Yichonghui Biotec

(1)

Nanjing Zeheng Pharmaceut

(1)

Nanjing Zhihe Pharmaceuti

(1)

Nankai University

(1)

Nanovish Therapeutics Inc

(1)

Nantong Jiuhe Pharmaceuti

(1)

Nantong Sanyue Traditiona

(1)

Nantong Senxuan Pharmaceu

(1)

Nanyang Shanhe New Materi

(1)

Nanyang Technological Uni

(1)

Nanyang Xinsheng Pharmace

(1)

Naval Medical Univ

(1)

Navidea Biopharmaceutical

(1)

Navigo Proteins

(1)

Neurocrine Biosciences

(1)

Neurocrine Uk Ltd

(1)

(1)

Neuroregeneration Pharma

(1)

New York Institute Of Tec

(1)

Newave Pharmaceutical

(1)

Nexra Pharmaceuticals Uk

(1)

Nextgen Bioscience

(1)

Nimbus Salacia Inc

(1)

Ningbo Sanhuan Hospital

(1)

Ningbo University

(1)

Ningxia Medical Universit

(1)

Nippharma Co Ltd

(1)

Nnocare Pharma Inc

(1)

No 1 Affiliated Hospital

(1)

No 1 People\'s Hospital o

(1)

Northern Digital Inc

(1)

NovaRock Biotherapeutics

(1)

(1)

Novartis Pharma

(1)

(1)

Nurix Therapeutics

(1)

Nxera Pharma UK

(1)

Odyssey Therapeutics

(1)

Ohio State Innovatiion Fo

(1)

Olatec Therapeutics Inc

(1)

Olema Pharmaceuticals Inc

(1)

Olfactive Al Inc

(1)

OliX Pharmaceuticals

(1)

Omega Therapeutics Inc

(1)

Oncoc4 Inc [us]; Universi

(1)

(1)

Oncospherix Inc

(1)

Ontrac Therapeutics Inc

(1)

Oranger Dtx Tianjin Co Lt

(1)

Orvia Pharmaceuticals Inc

(1)

Osaka Pharmaceutical Co L

(1)

Oxeia Biopharmaceuticals

(1)

Oxford University Innovat

(1)

Oxybio Ltd; Chicago An &

(1)

Oyster Point Pharma

(1)

PPG Industries, Ohio

(1)

Peking University First H

(1)

Peking University Third H

(1)

Peking University Third H

(1)

Peptide Bioscience Llc

(1)

Peter Maccallum Cancer In

(1)

(1)

(1)

(1)

Pharmaceutical Factory Of

(1)

Pharmaceutical Factory Of

(1)

(1)

Pharos Ibio Co Ltd [kr];

(1)

Pheon Therapeutics

(1)

(1)

Plastic Surgery Hospital,

(1)

Polifarma Nanjing Co Ltd

(1)

Polypeptide Therapeutic S

(1)

Porton Pharma Solutions

(1)

Poseida Therapeutics

(1)

Powerchina Kunming Engine

(1)

Praxis Precision Medicine

(1)

President And Fellows Of

(1)

Previpharma Gmbh

(1)

(1)

(1)

Propedix Inc [us]; Schanb

(1)

Provectus Pharmatech Inc

(1)

Provectus Pharmatech Inc;

(1)

Pubaisi Bio Tech Suzhou C

(1)

Public Univ Corporation N

(1)

(1)

(1)

Qide Pharmaceutical Tech

(1)

Qilu Pharmaceutical

(1)

Qingdao Artai Gene Co Ltd

(1)

Qingdao Inst Bioenergy &

(1)

Qingdao Prociva Therapeut

(1)

Qingdao Runda Biotechnolo

(1)

Qingdao Sino Cell Biomedi

(1)

Qingdao University

(1)

Qinghai University for Na

(1)

Qinhuangdao Health School

(1)

Qinhuangdao Shidian Tech

(1)

Quaerite Biopharm Researc

(1)

Qualia Life Sciences Llc

(1)

(1)

R P Scherer Technologies

(1)

ROHTO Pharmaceutical

(1)

Recursion Pharmaceuticals

(1)

Redcarbonpharm Ltd

(1)

(1)

Refine Holdings Co Ltd

(1)

Regulus Therapeutics

(1)

Remegen Biopharmaceutical

(1)

Renhe Yikang Group Co Ltd

(1)

Research & Development In

(1)

Reviva Pharmaceuticals In

(1)

Revolo Biotherapeutics

(1)

Reyoung Pharmaceutical

(1)

Riconpharma Llc

(1)

Ringpu Baoding Biological

(1)

Roche Diagnostics Gmbh [d

(1)

Roquette Freres

(1)

Rugao Ruandezhang Clinic;

(1)

Ruijin Hospital Shanghai

(1)

Ruijin Hospital Shanghai

(1)

Ruijin Yuntian Pharmacy C

(1)

Ruiyin Cell Engineering T

(1)

Rutgers University

(1)

SNIPR Technology

(1)

ST Dolicon Pharmaceutical

(1)

SZYY Group Pharmaceutical

(1)

Sage Therapeutics

(1)

Saiweitai Guangzhou Healt

(1)

Samsung Life Public Welfa

(1)

Samyang Holdings

(1)

(1)

Sanofi Sa [fr]; Inst Nat

(1)

Sanovel Ilac Sanayi Ve Ti

(1)

Santa Isabel Int Foundati

(1)

Sanya Yazhouwan Deep Sea

(1)

Sato Yuichi [jp]; Inoue R

(1)

(1)

(1)

Seo Suk Bae; Kim Ja Young

(1)

Seoul National University

(1)

Servier Laboratories

(1)

Servier Pharmaceuticals

(1)

Shaanxi Fengdan Zhengyuan

(1)

Shaanxi Fengdi Pharmaceut

(1)

Shaanxi Pharmaceutical Ho

(1)

Shaanxi Zhuocheng Medical

(1)

(1)

Shandong Anxin Pharmaceut

(1)

Shandong Da Nong Pharmacy

(1)

Shandong Guobang Pharmace

(1)

Shandong Hongjitang Tradi

(1)

Shandong Huihua Wangyan P

(1)

Shandong Institute of Med

(1)

Shandong Mingren Furuida

(1)

Shandong New Time Pharmac

(1)

Shandong Nhu Pharmaceutic

(1)

Shandong Nuomingkang Phar

(1)

Shandong Nuomingkang Phar

(1)

Shandong Runjun Pharmaceu

(1)

Country

X

China Patent News

WIPO Patent News

European Patent News

Status

X

1 - 100 of 1768 Items

Sign In / Subscribe

Select All

Share
Download as Excel
Download as PDF

Guangzhou Minle Network Tech Co Ltd Submits Chinese Patent Application for Bispecific Antibody Fusion Protein Simultaneously Targeting Bmp-2 and Vegf-a and Application of Bispecifi..

Pharmaceutical

| Sun 29 Mar 2026

Beijing, March 30 -- Guangzhou Minle Network Tech Co Ltd has submitted a patent application for Bispecific Antibody Fusion Protein Simultaneously Targeting Bmp-2 and Vegf-a and Application of Bispecific Antibody Fusion Protein in Preparation of Drugs for Treating Diabetic Retinopathy. This invention was developed by Zhang Ziran,..

State Intellectual Property Office of China Receives Kangyuan Bochuang Bio Tech Beijing Co Ltd Patent Application for Anti-egfr And/or Pd-l1 Antibody and Application Thereof

Pharmaceutical

| Sun 29 Mar 2026

Beijing, March 30 -- State Intellectual Property Office of China has received Kangyuan Bochuang Bio Tech Beijing Co Ltd patent application for Anti-egfr And/or Pd-l1 Antibody and Application Thereof. Ning Jinying, Peng Hao, Wu Guojin and Hao Feng developed the invention. The patent application number is CN202510627180 2025051..

Oyster Point Pharma Submits Patent Application for Dispenser Configured for Aseptic Transfer of a Liquid Product

Pharmaceutical

| Mon 30 Mar 2026

Alexandria, March 30 -- Oyster Point Pharma has submitted a patent application for Dispenser Configured for Aseptic Transfer of a Liquid Product. Lokhnauth John K, Ehrnsperger Eric C, Buel Travis D, Lepree Jason M, Donato George J, Nau Jeffey Allen, Smith Peter A, Ranalletta Joseph Vincent and Nichols Eli B developed the inventi..

U.S. Patent and Trademark Office Publishes SCHOTT Pharma Patent Application for Stacking of Nests for Pharmaceutical Containers

Pharmaceutical

| Mon 30 Mar 2026

Alexandria, March 30 -- U.S. Patent and Trademark Office has published SCHOTT Pharma patent application for Stacking of Nests for Pharmaceutical Containers. The invention was developed by Berlinger Marcel and Bieg Jörg Christoph. The patent application number is US202519334411 20250919. The patent publication number is US20260..

SCHOTT Pharma Seeks Patent for Stacking of Nests for Pharmaceutical Containers

Pharmaceutical

| Mon 30 Mar 2026

Alexandria, March 30 -- SCHOTT Pharma has sought patent for Stacking of Nests for Pharmaceutical Containers. This invention was developed by Berlinger Marcel and Bieg Jörg Christoph. The patent application number is US202519332225 20250918. The patent publication number is US20260083634 (A1). International Patent Classificat..

Wang Tianxin Submits United States Patent Application for Methods and Devices for the Treatment and Relief of Dry Eye Symptoms

Pharmaceutical

| Mon 30 Mar 2026

Alexandria, March 30 -- Wang Tianxin has submitted a patent application for Methods and Devices for the Treatment and Relief of Dry Eye Symptoms. The patent application number is US202519405389 20251202. The patent publication number is US20260083633 (A1). International Patent Classification codes are A61F9/02, A61H35/02 and A6..

State Intellectual Property Office of China Receives Shijiazhuang No 4 Pharmaceutical Patent Application for Infusion Bag of Compound Mannitol Injection and Preparation Method of I..

Pharmaceutical

| Mon 30 Mar 2026

Beijing, March 30 -- State Intellectual Property Office of China has received Shijiazhuang No 4 Pharmaceutical patent application for Infusion Bag of Compound Mannitol Injection and Preparation Method of Infusion Bag. Wang Hui, Wang Qiaru, Zhang Sumei, Yan Yongna and Zhang Xuexia developed the invention. The patent application ..

State Intellectual Property Office of China Receives Tianjin University Patent Application for Intelligent Microstructure Seal for Large-area Micro Transfer Printing and Micro Tran..

Pharmaceutical

| Mon 30 Mar 2026

Beijing, March 30 -- State Intellectual Property Office of China has received Tianjin University patent application for Intelligent Microstructure Seal for Large-area Micro Transfer Printing and Micro Transfer Printing Method Thereof. Liang Cunman, Guo Fucheng, Zhong Yijie, Shi Beichao and Wang Fujun developed the invention. Th..

Xiamen Kangji Biotechnology Co Ltd Seeks Patent for Monoclonal Antibody of Folic Acid and Folic Acid Receptor Protein Compound and Application Thereof

Pharmaceutical

| Sun 29 Mar 2026

Beijing, March 30 -- Xiamen Kangji Biotechnology Co Ltd has sought patent for Monoclonal Antibody of Folic Acid and Folic Acid Receptor Protein Compound and Application Thereof. This invention was developed by Yang Zhiwei, Zhang Yonglei, Wang Yaying, Zhang Minghui, Shen Jiepeng, Huang Fenfei, Zhou Bin and Yang Pingping. The p..

Xiamen Kangji Biotechnology Co Ltd Files Chinese Patent Application for Cortisol Compound Antibody and Application

Pharmaceutical

| Sun 29 Mar 2026

Beijing, March 30 -- Xiamen Kangji Biotechnology Co Ltd has filed a patent application for Cortisol Compound Antibody and Application. This invention was developed by Zhou Bin, Zhang Yonglei, Li Yangxin, Li Mengmeng, Lu Yiyan, Yang Pingping, Yang Zhiwei and Huang Fenfei. The patent application number is CN202511100796 2025080..

State Intellectual Property Office of China Releases Center For Excellence In Brain Science and Intelligence Tech Chinese Academy Of Sciences Patent Application for Anti-nmda Recep..

Pharmaceutical

| Sun 29 Mar 2026

Beijing, March 30 -- State Intellectual Property Office of China has released Center For Excellence In Brain Science and Intelligence Tech Chinese Academy Of Sciences patent application for Anti-nmda Receptor Antibody and Application Thereof. This invention was developed by Zhu Shujia, Xie Chun, Song Nan, Wang Han, Huang Xuejing..

State Intellectual Property Office of China Receives Beijing Subenyuanhe Biotechnology Co Ltd Patent Application for Monoclonal Antibody Pair for Detecting Cat Immunodeficiency Vir..

Pharmaceutical

| Sun 29 Mar 2026

Beijing, March 30 -- State Intellectual Property Office of China has received Beijing Subenyuanhe Biotechnology Co Ltd patent application for Monoclonal Antibody Pair for Detecting Cat Immunodeficiency Virus P24 Protein and Application Thereof. Qin Kun, Lu Shuai, Li Yue, Sun Yutian, Zhong Ming and Su Du developed the invention. ..

Beijing Subenyuanhe Biotechnology Co Ltd Submits Patent Application for Monoclonal Antibody Combination for Detecting Canine Parainfluenza Virus NP Protein and Application Thereof

Pharmaceutical

| Sun 29 Mar 2026

Beijing, March 30 -- Beijing Subenyuanhe Biotechnology Co Ltd has submitted a patent application for Monoclonal Antibody Combination for Detecting Canine Parainfluenza Virus NP Protein and Application Thereof. Qin Kun, Lu Shuai, Li Yue, Sun Yutian, Zhong Ming and Su Du developed the invention. The patent application number is..

State Intellectual Property Office of China Publishes Hangzhou Baotai Biotechnology Co Ltd and Xiamen Kangji Biotechnology Co Ltd Patent Application for Influenza B Virus NP Protei..

Pharmaceutical

| Sun 29 Mar 2026

Beijing, March 30 -- State Intellectual Property Office of China has published Hangzhou Baotai Biotechnology Co Ltd and Xiamen Kangji Biotechnology Co Ltd patent application for Influenza B Virus NP Protein Monoclonal Antibody 10g11 and Application Thereof. The invention was developed by Zhang Yonglei, Peng Bo, Li Yanqun, Yang Z..

Hangzhou Biogenome Biotechnology Co Ltd Applies for Patent on Novel FC-effect-eliminated Framework Flow Antibody as Well as Preparation Method and Application of Novel Fc-effect-el..

Pharmaceutical

| Sun 29 Mar 2026

Beijing, March 30 -- Hangzhou Biogenome Biotechnology Co Ltd has applied Chinese patent for Novel FC-effect-eliminated Framework Flow Antibody as Well as Preparation Method and Application of Novel Fc-effect-eliminated Framework Flow Antibody. Deng Chunquan, Wang Qiongqiong, Yang Xiaoning, Wu Rongying, Chen Ying, Li Yi, Zheng Bi..

State Intellectual Property Office of China Receives Longhu Modern Immunology Laboratory Patent Application for Polypeptide of HCV E2 Protein B Cell Epitope, Monoclonal Antibody an..

Pharmaceutical

| Sun 29 Mar 2026

Beijing, March 30 -- State Intellectual Property Office of China has received Longhu Modern Immunology Laboratory patent application for Polypeptide of HCV E2 Protein B Cell Epitope, Monoclonal Antibody and Application. Wang Aiping, Wang Haili, Zhou Jingming, Chen Yumei, Liu Yankai, You Xiaojuan, Wang Xinzhou and Li Yongxin deve..

State Intellectual Property Office of China Releases Shandong University and Shandong Daohe Pharmaceutical Co Ltd Patent Application for Synthesis Method of Polycyclic Compound and..

Pharmaceutical

| Sun 29 Mar 2026

Beijing, March 30 -- State Intellectual Property Office of China has released Shandong University and Shandong Daohe Pharmaceutical Co Ltd patent application for Synthesis Method of Polycyclic Compound and Intermediate. This invention was developed by Zhao Xuting, Kim Kang, Fang Hao and Song Weiguo. The patent application num..

Capital University of Medical Sciences Submits Chinese Patent Application for Ibuprofen-tyr-arg-tyr-arg and Preparation and Application Thereof

Pharmaceutical

| Sun 29 Mar 2026

Beijing, March 30 -- Capital University of Medical Sciences has submitted a patent application for Ibuprofen-tyr-arg-tyr-arg and Preparation and Application Thereof. This invention was developed by Zhao Ming, Zhang Xiaoyi, Feng Qiqi and Jin Pengrui. The patent application number is CN202511374733 20250925. The patent publicat..

State Intellectual Property Office of China Publishes Shanghai Institute Of Pharmaceutical Industry Co Ltd and China State Inst Of Pharmaceutical Industry Co Ltd Patent Application..

Pharmaceutical

| Sun 29 Mar 2026

Beijing, March 30 -- State Intellectual Property Office of China has published Shanghai Institute Of Pharmaceutical Industry Co Ltd and China State Inst Of Pharmaceutical Industry Co Ltd patent application for Cryptotanshinone Derivative as Well as Preparation Method and Medical Application Thereof. The invention was developed b..

Wuhan Jiulong Humanwell Pharmaceutical Co Ltd Seeks Patent for Methylprednisolone Dimer Impurity and Separation and Purification Method Thereof

Pharmaceutical

| Sun 29 Mar 2026

Beijing, March 30 -- Wuhan Jiulong Humanwell Pharmaceutical Co Ltd has sought patent for Methylprednisolone Dimer Impurity and Separation and Purification Method Thereof. This invention was developed by Fu Jie, Li Jie, Huang Wenlian, Zhou Kai, Wang Yang, Liu Cheng, Luo Siyu, Zhu Xiaoshan, Di Feifei and Li Yaqi. The patent app..

State Intellectual Property Office of China Publishes Jiuzhou Pharmaceutical Hangzhou Co Ltd and Zhejiang Raybow Pharmaceutical Patent Application for Preparation Method of Novel F..

Pharmaceutical

| Sun 29 Mar 2026

Beijing, March 30 -- State Intellectual Property Office of China has published Jiuzhou Pharmaceutical Hangzhou Co Ltd and Zhejiang Raybow Pharmaceutical patent application for Preparation Method of Novel Ferrocene Pyridine Hydrazine Manganese Complex. The invention was developed by Chen Jinkang, Chen Bin, Zhu Xudong, Yan Pucha a..

China Pharmaceutical University Seeks Patent for Oxaprozin Coupled Cis-platinum Compound as Well as Preparation Method and Application Thereof

Pharmaceutical

| Sun 29 Mar 2026

Beijing, March 30 -- China Pharmaceutical University has sought patent for Oxaprozin Coupled Cis-platinum Compound as Well as Preparation Method and Application Thereof. This invention was developed by Ding Ya, Chen Chuying and Luo Xiaoqing. The patent application number is CN20251138644 20250728. The patent publication number ..

Haisco Pharmaceutical Group Inc Files Chinese Patent Application for Heterocyclic Compound and Application Thereof in Medicine

Pharmaceutical

| Sun 29 Mar 2026

Beijing, March 30 -- Haisco Pharmaceutical Group Inc has filed a patent application for Heterocyclic Compound and Application Thereof in Medicine. This invention was developed by Zhang Chen, Liao Yuting, Chen Zhen, Li Yupeng, Takaaki, Zou Sijia, Li Yao and Yan Pangke. The patent application number is CN202510611965 20250513. ..

State Intellectual Property Office of China Receives Peking University Third Hospital Patent Application for ALK-targeted Compound and Application Thereof

Pharmaceutical

| Sun 29 Mar 2026

Beijing, March 30 -- State Intellectual Property Office of China has received Peking University Third Hospital patent application for ALK-targeted Compound and Application Thereof. Xiao Yu and Liu Zhentao developed the invention. The patent application number is CN202511113672 20250808. The patent publication number is CN1209..

China Resources Double Crane Pharmaceutical Co Ltd Applies for Patent on Crystal Form of Brutinib as Well as Preparation Method and Application of Crystal Form

Pharmaceutical

| Sun 29 Mar 2026

Beijing, March 30 -- China Resources Double Crane Pharmaceutical Co Ltd has applied Chinese patent for Crystal Form of Brutinib as Well as Preparation Method and Application of Crystal Form. Cheng Yuan, Wang Hongzheng, Chang Yan and Liu Moyi developed it. The patent application number is CN20251192095 20250805. The patent pub..

State Intellectual Property Office of China Receives Anhui Xintai Pharmaceutical Co Ltd Patent Application for Traditional Chinese Medicinal Material Beard Removing Equipment

Pharmaceutical

| Sun 29 Mar 2026

Beijing, March 30 -- State Intellectual Property Office of China has received Anhui Xintai Pharmaceutical Co Ltd patent application for Traditional Chinese Medicinal Material Beard Removing Equipment. Song Xuecai and Wu Zhe developed the invention. The patent application number is CN202510965483 20250714. The patent publicati..

Shanghai Yishi Pharmaceutical Tech Co Ltd Submits Chinese Patent Application for Preparation Method and Application of Dihydrothienopyrimidine Derivative

Pharmaceutical

| Sun 29 Mar 2026

Beijing, March 30 -- Shanghai Yishi Pharmaceutical Tech Co Ltd has submitted a patent application for Preparation Method and Application of Dihydrothienopyrimidine Derivative. This invention was developed by Wang Feng, Song Yunlong, Wang Pengpeng, Wang Disha, Kou Hongyan and Yu Ning. The patent application number is CN2025106..

Research & Development Institute of Northwestern Polytechnical University in Shenzhen Applies for Patent on Preparation and Anti-tumor Application of Novel 6-diazo-5-oxo-n-leucine ..

Pharmaceutical

| Sun 29 Mar 2026

Beijing, March 30 -- Research & Development Institute of Northwestern Polytechnical University in Shenzhen has applied Chinese patent for Preparation and Anti-tumor Application of Novel 6-diazo-5-oxo-n-leucine Derivative Prodrug. Wei Gaofei, Fan Renming, Lu Xintong, Chen Ye, Hai Yongrui and Yan Zhongzuo developed it. The pate..

State Intellectual Property Office of China Receives Capital University of Medical Sciences Patent Application for Method for Synthesizing Polysubstituted 2, 7-dioxo-bicyclo [3.2. ..

Pharmaceutical

| Sun 29 Mar 2026

Beijing, March 30 -- State Intellectual Property Office of China has received Capital University of Medical Sciences patent application for Method for Synthesizing Polysubstituted 2, 7-dioxo-bicyclo [3.2. 1] Octane Compound Under Catalysis of Haloid Acid. Ma Dengke, Xie Chengyan, Tan Jun, Xu Mingyang and Zhang Yifei developed th..

Guangdong HEC Pharmaceutical Submits Patent Application for Pyrimidino Aromatic Ring Compound and Application Thereof in Medicine

Pharmaceutical

| Sun 29 Mar 2026

Beijing, March 30 -- Guangdong HEC Pharmaceutical has submitted a patent application for Pyrimidino Aromatic Ring Compound and Application Thereof in Medicine. Yan Guanghua, Li Jing, Chen Yunfu, Xiao Yanyun, Mo Zhuowen, Bai Changlin and Wang Pu developed the invention. The patent application number is CN202410615340 20240517. T..

Jiangsu Weiqida Pharmaceutical Co Ltd Submits Chinese Patent Application for Preparation Method of Tofacitinib Citrate

Pharmaceutical

| Sun 29 Mar 2026

Beijing, March 30 -- Jiangsu Weiqida Pharmaceutical Co Ltd has submitted a patent application for Preparation Method of Tofacitinib Citrate. This invention was developed by Xiong Jimin, Lei Dong, Shi Dan, Fan Hengchang, Li Chungang and He Kangyong. The patent application number is CN202511166162 20250819. The patent publicati..

State Intellectual Property Office of China Receives Shanghai Hansoh Biomedical and Jiangsu Hansoh Pharmaceutical Group Patent Application for Olefin Derivative Inhibitor as Well a..

Pharmaceutical

| Sun 29 Mar 2026

Beijing, March 30 -- State Intellectual Property Office of China has received Shanghai Hansoh Biomedical and Jiangsu Hansoh Pharmaceutical Group patent application for Olefin Derivative Inhibitor as Well as Preparation Method and Application Thereof. Zeng Mi, Gao Peng, Li Jian, Wang Zhiwei and Ma Jialong developed the invention...

State Intellectual Property Office of China Receives Nanjing Zhihe Pharmaceutical Tech Co Ltd Patent Application for Novel Cgrp Receptor Antagonist and Application Thereof

Pharmaceutical

| Sun 29 Mar 2026

Beijing, March 30 -- State Intellectual Property Office of China has received Nanjing Zhihe Pharmaceutical Tech Co Ltd patent application for Novel Cgrp Receptor Antagonist and Application Thereof. Fu Haijian, Li Xiangyang and Jiang Long developed the invention. The patent application number is CN202510636308 20250516. The pa..

State Intellectual Property Office of China Publishes Nanjing Zaiming Pharmaceutical Co Ltd Patent Application for Ring-fused Compound and Application Thereof

Pharmaceutical

| Sun 29 Mar 2026

Beijing, March 30 -- State Intellectual Property Office of China has published Nanjing Zaiming Pharmaceutical Co Ltd patent application for Ring-fused Compound and Application Thereof. The invention was developed by Zhou Muxing, Wang Juan, Yang Yang, Wang Weikun, Yu Jian, Li Zhengtao and Tang Renhong. The patent application n..

Hanghzou Bio Sincerity Pharma Tech Cop Ltd Submits Chinese Patent Application for GLP-1 Receptor Agonist and Application Thereof in Medicine

Pharmaceutical

| Sun 29 Mar 2026

Beijing, March 30 -- Hanghzou Bio Sincerity Pharma Tech Cop Ltd has submitted a patent application for GLP-1 Receptor Agonist and Application Thereof in Medicine. This invention was developed by Zhang Jinzhu, Liu Chuanduo, Li Yuanyuan, Tian Yuan, Shao Shuai, Lei Shaowei, Cheng Didi, Shen Ximing, Miao Lei, Wang Jianghai, Feng Eng..

Shanghai Institute of Materia Medica, Chinese Academy of Sciences Submits Chinese Patent Application for Yohimbine Derivative as Well as Preparation Method, Pharmaceutical Composit..

Pharmaceutical

| Sun 29 Mar 2026

Beijing, March 30 -- Shanghai Institute of Materia Medica, Chinese Academy of Sciences has submitted a patent application for Yohimbine Derivative as Well as Preparation Method, Pharmaceutical Composition and Application Thereof. This invention was developed by Nan Fajun, Li Jingya, Wang Jingyi and Cui Shichao. The patent appli..

Reyoung Pharmaceutical Submits Patent Application for Aqueous Phase Preparation Process for Improving Stability of Azilsartan Crystal Form

Pharmaceutical

| Sun 29 Mar 2026

Beijing, March 30 -- Reyoung Pharmaceutical has submitted a patent application for Aqueous Phase Preparation Process for Improving Stability of Azilsartan Crystal Form. Hu Qingwen, Wu Guoliang, Zhang Xiaowei and Liu Dejie developed the invention. The patent application number is CN202511397527 20250928. The patent publication n..

West China Hospital, Sichuan University Seeks Patent for Quinoline Compound, Preparation Method, Application and Pharmaceutical Composition Thereof

Pharmaceutical

| Sun 29 Mar 2026

Beijing, March 30 -- West China Hospital, Sichuan University has sought patent for Quinoline Compound, Preparation Method, Application and Pharmaceutical Composition Thereof. This invention was developed by Ye Tinghong, Su Xingping, Seol Tae-woong, Bai Yuanmei, Liu Zhihao, Cao Zhongwei, Jung Bok-sen, Luo Fengming and Wei Yuquan...

State Intellectual Property Office of China Releases Fudan University Patent Application for Application of Compound in Preparation of Mycobacterium Inhibitor

Pharmaceutical

| Sun 29 Mar 2026

Beijing, March 30 -- State Intellectual Property Office of China has released Fudan University patent application for Application of Compound in Preparation of Mycobacterium Inhibitor. This invention was developed by Lyu Liangdong and Wang Yixin. The patent application number is CN202511168721 20250820. The patent publication..

Southwest Jiaotong University Files Chinese Patent Application for Synthesis and Application of Seca Targeted Inhibitor Swht124

Pharmaceutical

| Sun 29 Mar 2026

Beijing, March 30 -- Southwest Jiaotong University has filed a patent application for Synthesis and Application of Seca Targeted Inhibitor Swht124. This invention was developed by Huang Xinhe, Liu Yan, Wang Zonglin, Wang Ningyu and Ming Yisen. The patent application number is CN20251198245 20250806. The patent publication num..

State Intellectual Property Office of China Publishes Shanxi Medical University Patent Application for C2-quaternary Carbon Indole-3-ketone Compound as Well as Preparation Method a..

Pharmaceutical

| Sun 29 Mar 2026

Beijing, March 30 -- State Intellectual Property Office of China has published Shanxi Medical University patent application for C2-quaternary Carbon Indole-3-ketone Compound as Well as Preparation Method and Application Thereof. The invention was developed by Ban Shurong, Zhang Hongyu, Tang Li, Wei Bei, Liu Xiao and Yu Qimei. ..

State Intellectual Property Office of China Releases Wuhan University of Science and Technology Patent Application for Topiroxostat Malonate Crystal Form A

Pharmaceutical

| Sun 29 Mar 2026

Beijing, March 30 -- State Intellectual Property Office of China has released Wuhan University of Science and Technology patent application for Topiroxostat Malonate Crystal Form A. This invention was developed by Zhang Hailu, Lee Jang-young, Wang Chiyi and Deng Zongwu. The patent application number is CN202511103315 20250807..

Jiangsu Ocean University Seeks Patent for Compound Combining Quinazoline Derivative and Pomalidomide as Well as Preparation Method and Application of Compound

Pharmaceutical

| Sun 29 Mar 2026

Beijing, March 30 -- Jiangsu Ocean University has sought patent for Compound Combining Quinazoline Derivative and Pomalidomide as Well as Preparation Method and Application of Compound. This invention was developed by Wang Xiujun and Hao Huihui. The patent application number is CN20251145231 20250722. The patent publication n..

Novartis Pharma Submits Patent Application for Compounds and Compositions for Treating Diseases Associated with Sting Activity

Pharmaceutical

| Sun 29 Mar 2026

Beijing, March 30 -- Novartis Pharma has submitted a patent application for Compounds and Compositions for Treating Diseases Associated with Sting Activity. Seidel Hans Martin, Roush William R, Venkatraman Srikanth and Katz Jonathan developed the invention. The patent application number is CN202511145327 20201230. The patent pu..

State Intellectual Property Office of China Publishes Shandong New Time Pharmaceutical Products Patent Application for Preparation Method of Brexpiprazole

Pharmaceutical

| Sun 29 Mar 2026

Beijing, March 30 -- State Intellectual Property Office of China has published Shandong New Time Pharmaceutical Products patent application for Preparation Method of Brexpiprazole. The invention was developed by Bao Guanglong, Cui Weichen and Bai Xuedong. The patent application number is CN202410609641 20240516. The patent publ..

Anhui Xingzhou Pharmaceutical Co Ltd Submits Chinese Patent Application for Gluconic Acid-delta-lactone Continuous Crystallization Production Process and Gluconic Acid-delta-lacton..

Pharmaceutical

| Sun 29 Mar 2026

Beijing, March 30 -- Anhui Xingzhou Pharmaceutical Co Ltd has submitted a patent application for Gluconic Acid-delta-lactone Continuous Crystallization Production Process and Gluconic Acid-delta-lactone. This invention was developed by Chen Zhiqiao, Mei Xianlong, Xiao Liping, Weng Yanpeng, Li Yaoqiang and Chen Guangkui. The p..

State Intellectual Property Office of China Receives Chia Tai Tianqing Pharmaceutical Group Patent Application for Preparation Method and Application of GLP-1 Receptor Agonist Inte..

Pharmaceutical

| Sun 29 Mar 2026

Beijing, March 30 -- State Intellectual Property Office of China has received Chia Tai Tianqing Pharmaceutical Group patent application for Preparation Method and Application of GLP-1 Receptor Agonist Intermediate. Zhu Yan, Liu Baomin and Chen Shaowei developed the invention. The patent application number is CN202510633253 20..

SHL Medical Seeks Patent for Voice Interrogation, Control, and Authentication of Connected Drug Delivery Devices

Pharmaceutical

| Mon 30 Mar 2026

Alexandria, March 30 -- SHL Medical has sought patent for Voice Interrogation, Control, and Authentication of Connected Drug Delivery Devices. This invention was developed by Coyne III Martin Michael, Ford Brigham Katherine and Franzese Christopher James. The patent application number is US202319109340 20230901. The patent pu..

U.S. Patent and Trademark Office Receives Shenzhen Nuon Medical Equipment Co Ltd Patent Application for Multifunctional Combination Hair Comb with Therapeutic Functions

Pharmaceutical

| Mon 30 Mar 2026

Alexandria, March 30 -- U.S. Patent and Trademark Office has received Shenzhen Nuon Medical Equipment Co Ltd patent application for Multifunctional Combination Hair Comb with Therapeutic Functions. Dijkstra Alain, Xiang Li, Yuanzhou Tang and Jianxin Feng developed the invention. The patent application number is US202519304622..

U.S. Patent and Trademark Office Releases Aphea Bio NV and Fundacion Centro De Excelencia En Investig De Medicamentos Innovadores En Andalucia Medina Patent Application for Means a..

Pharmaceutical

| Mon 30 Mar 2026

Alexandria, March 30 -- U.S. Patent and Trademark Office has released Aphea Bio NV and Fundacion Centro De Excelencia En Investig De Medicamentos Innovadores En Andalucia Medina patent application for Means and Methods for Controlling Pathogens and Pests in Plants. This invention was developed by Lagae Emma, Simon Thomas, Vercau..

State Intellectual Property Office of China Publishes Beijing Renwei Pharmaceutical Co Ltd Patent Application for Medicine Residue Filtering Equipment and Medicine Residue Separati..

Pharmaceutical

| Mon 30 Mar 2026

Beijing, March 30 -- State Intellectual Property Office of China has published Beijing Renwei Pharmaceutical Co Ltd patent application for Medicine Residue Filtering Equipment and Medicine Residue Separation Method During Preparation of Traditional Chinese Medicine Decoction Piece Liquid Medicine. The invention was developed by ..

State Intellectual Property Office of China Releases Jiangsu Houbang Ind Co Ltd Patent Application for Polyvinyl Chloride Composite Material for Medicine Packaging and Preparation ..

Pharmaceutical

| Mon 30 Mar 2026

Beijing, March 30 -- State Intellectual Property Office of China has released Jiangsu Houbang Ind Co Ltd patent application for Polyvinyl Chloride Composite Material for Medicine Packaging and Preparation Method Thereof. This invention was developed by Shen Yiming, Guo Hongchun and Jiang Yutao. The patent application number i..

Healios Therapeutics Llc Seeks Patent for Hyperthermia for Surface Cancers

Pharmaceutical

| Mon 30 Mar 2026

Alexandria, March 30 -- Healios Therapeutics Llc has sought patent for Hyperthermia for Surface Cancers. This invention was developed by Agarwal Ankit and Greene David Erik. The patent application number is US202418930025 20241029. The patent publication number is US20260083979 (A1). International Patent Classification code i..

Gachon University Of Industry Academic Cooperation Foundation and Quadmedicine Inc File United States Patent Application for Microneedle Patch and Method for Manufacturing the Same

Pharmaceutical

| Mon 30 Mar 2026

Alexandria, March 30 -- Gachon University Of Industry Academic Cooperation Foundation and Quadmedicine Inc have filed a patent application for Microneedle Patch and Method for Manufacturing the Same. This invention was developed by Baek Seung Ki, Park Jung Hwan, Kwon Min Ju and Ryu Min Woo. The patent application number is US..

Chiesi Farmaceutici Submits Patent Application for Capsule Inhaler for the Administration of a Phosphodiesterase-4 Inhibitor

Pharmaceutical

| Mon 30 Mar 2026

Alexandria, March 30 -- Chiesi Farmaceutici has submitted a patent application for Capsule Inhaler for the Administration of a Phosphodiesterase-4 Inhibitor. Buttini Francesca, Varacca Giada and Osello Romina developed the invention. The patent application number is US202319112743 20230921. The patent publication number is US20..

U.S. Patent and Trademark Office Releases Guangzhou Anobri Pharmaceutical Co Ltd Patent Application for Atomizing Body Assembly and Soft Mist Device with Improved Sealing Performan..

Pharmaceutical

| Mon 30 Mar 2026

Alexandria, March 30 -- U.S. Patent and Trademark Office has released Guangzhou Anobri Pharmaceutical Co Ltd patent application for Atomizing Body Assembly and Soft Mist Device with Improved Sealing Performance. This invention was developed by Huang Cai Gu and Chen Shan Ming. The patent application number is US202219106729 20..

Agnes Medical Co Ltd Seeks Patent for Needle Module Capable of Injecting Medicine

Pharmaceutical

| Mon 30 Mar 2026

Alexandria, March 30 -- Agnes Medical Co Ltd has sought patent for Needle Module Capable of Injecting Medicine. This invention was developed by Ahn Gunyoung, Hong Hyuck Ki, Jung Kyoung Su, Shin Moon Ki and Cha Byoung Jun. The patent application number is US202519085103 20250320. The patent publication number is US20260083919 ..

Sanofi Submits United States Patent Application for Assembly for a Drug Delivery Device and Drug Delivery Device

Pharmaceutical

| Mon 30 Mar 2026

Alexandria, March 30 -- Sanofi has submitted a patent application for Assembly for a Drug Delivery Device and Drug Delivery Device. This invention was developed by Dasbach Uwe, Kemp Thomas Mark and Denyer Timothy. The patent application number is US202519404414 20251201. The patent publication number is US20260083916 (A1). Inte..

U.S. Patent and Trademark Office Publishes SHL Medical Patent Application for a Medicament Delivery Device and a Subassembly of a Medicament Delivery Device

Pharmaceutical

| Mon 30 Mar 2026

Alexandria, March 30 -- U.S. Patent and Trademark Office has published SHL Medical patent application for a Medicament Delivery Device and a Subassembly of a Medicament Delivery Device. The invention was developed by Säll Daniel, Wang Tai-fu and Huang Chun-hsien. The patent application number is US202319110476 20230829. The pa..

U.S. Patent and Trademark Office Receives Angootioshnari Farshid Patent Application for Remote-controlled Rotating Hand Mechanism in Aesthetic Medicine

Pharmaceutical

| Mon 30 Mar 2026

Alexandria, March 30 -- U.S. Patent and Trademark Office has received Angootioshnari Farshid patent application for Remote-controlled Rotating Hand Mechanism in Aesthetic Medicine. Angootioshnari Farshid developed the invention. The patent application number is US202418894051 20240924. The patent publication number is US20260..

U.S. Patent and Trademark Office Receives Insulet Corporation Patent Application for Adjustment of Medicament Delivery by a Medicament Delivery Device Based on Menstrual Cycle Phas..

Pharmaceutical

| Mon 30 Mar 2026

Alexandria, March 30 -- U.S. Patent and Trademark Office has received Insulet Corporation patent application for Adjustment of Medicament Delivery by a Medicament Delivery Device Based on Menstrual Cycle Phase. Narayanaswami Rangarajan developed the invention. The patent application number is US202519405974 20251202. The patent..

University of Virginia Patent Foundation Seeks Patent for System and Method for Calculating an Insulin Dosing Function

Pharmaceutical

| Mon 30 Mar 2026

Alexandria, March 30 -- University of Virginia Patent Foundation has sought patent for System and Method for Calculating an Insulin Dosing Function. This invention was developed by El Fathi Anas, Breton Marc D, Pryor Elliott C, Tavasoli Ali and Shakeri Heman. The patent application number is US202519335674 20250922. The patent ..

U.S. Patent and Trademark Office Receives Dyno Therapeutics Patent Application for Capsid Polypeptides and Methods of Use Thereof

Pharmaceutical

| Mon 30 Mar 2026

Alexandria, March 30 -- U.S. Patent and Trademark Office has received Dyno Therapeutics patent application for Capsid Polypeptides and Methods of Use Thereof. Wolock Samuel, Malina Stephen and Briers Demarcus developed the invention. The patent application number is US202519342097 20250926. The patent publication number is US20..

R P Scherer Technologies Submits United States Patent Application for Thiazolidine Linkers for Protein-drug Conjugates and Uses Thereof

Pharmaceutical

| Mon 30 Mar 2026

Alexandria, March 30 -- R P Scherer Technologies has submitted a patent application for Thiazolidine Linkers for Protein-drug Conjugates and Uses Thereof. This invention was developed by Cai Xiao, Chuprakov Stepan, Nair Reji, Ogunkoya Ayodele and Smith Matthew. The patent application number is US202519325974 20250911. The pat..

Eli Lilly and Company Submits United States Patent Application for Conjugates Comprising Bis-mspt Linker

Pharmaceutical

| Mon 30 Mar 2026

Alexandria, March 30 -- Eli Lilly and Company has submitted a patent application for Conjugates Comprising Bis-mspt Linker. This invention was developed by Alam Riazul, Cortez Guillermo S and Wang Yan. The patent application number is US202519333454 20250919. The patent publication number is US20260083854 (A1). International Pa..

U.S. Patent and Trademark Office Publishes Viracta Therapeutics Inc Patent Application for Combination of CAR T-cell Therapy with BTK Inhibitors and Methods of Use Thereof

Pharmaceutical

| Mon 30 Mar 2026

Alexandria, March 30 -- U.S. Patent and Trademark Office has published Viracta Therapeutics Inc patent application for Combination of CAR T-cell Therapy with BTK Inhibitors and Methods of Use Thereof. The invention was developed by Fox Judith A and Taverna Pietro. The patent application number is US202218706903 20221102. The ..

Geneos Therapeutics Inc Files United States Patent Application for Vaccines and Methods of Using the Same to Treat Wnt-related Cancer

Pharmaceutical

| Mon 30 Mar 2026

Alexandria, March 30 -- Geneos Therapeutics Inc has filed a patent application for Vaccines and Methods of Using the Same to Treat Wnt-related Cancer. This invention was developed by Perales-puchalt Alfredo and Sardesai Niranjan. The patent application number is US202318865104 20230510. The patent publication number is US2026..

Yale University Submits United States Patent Application for Compositions and Methods for Treating, Ameliorating, and/or Preventing Diseases and/or Disorders

Pharmaceutical

| Mon 30 Mar 2026

Alexandria, March 30 -- Yale University has submitted a patent application for Compositions and Methods for Treating, Ameliorating, and/or Preventing Diseases and/or Disorders. This invention was developed by Braddock Demetrios, Stabach Paul and Lester Ethan. The patent application number is US202519326001 20250911. The paten..

CLS Therapeutics Ltd Seeks Patent for Immunomodulation of Tumor Microenvironment

Pharmaceutical

| Mon 30 Mar 2026

Alexandria, March 30 -- CLS Therapeutics Ltd has sought patent for Immunomodulation of Tumor Microenvironment. This invention was developed by Genkin Dmitry Dmitrievich, Tets Georgy Viktorovich and Tets Viktor Veniaminovich. The patent application number is US202519189164 20250424. The patent publication number is US202600838..

New York Institute Of Tech Submits United States Patent Application for Method for Ameliorating Autism Symptoms by Pharmacological Activation of the Neurotensin Receptor 1 (ntsr1)

Pharmaceutical

| Mon 30 Mar 2026

Alexandria, March 30 -- New York Institute Of Tech has submitted a patent application for Method for Ameliorating Autism Symptoms by Pharmacological Activation of the Neurotensin Receptor 1 (ntsr1). This invention was developed by Otazu Aldana Gonzalo Hugo. The patent application number is US202519349587 20251003. The patent ..

Ajou University Industry-Academic Cooperation Foundation Submits United States Patent Application for Composition for Inhibiting Toxicity of Nanoparticles and Environmentally-deriv..

Pharmaceutical

| Mon 30 Mar 2026

Alexandria, March 30 -- Ajou University Industry-Academic Cooperation Foundation has submitted a patent application for Composition for Inhibiting Toxicity of Nanoparticles and Environmentally-derived Fine Particles. This invention was developed by Lee Gwang, Shin Tae-hwan, Kang Yup, Kwak Jong-young and Lee Dayeon. The patent a..

U.S. Patent and Trademark Office Receives Teruya Terry Patent Application for Decarboxylated Cannabis Pill and Method of Producing the Pill

Pharmaceutical

| Mon 30 Mar 2026

Alexandria, March 30 -- U.S. Patent and Trademark Office has received Teruya Terry patent application for Decarboxylated Cannabis Pill and Method of Producing the Pill. The patent application number is US202519338449 20250924. The patent publication number is US20260083790 (A1). International Patent Classification codes are ..

U.S. Patent and Trademark Office Publishes Mycotech Pharma As Patent Application for Antiviral Fungal Extracts

Pharmaceutical

| Mon 30 Mar 2026

Alexandria, March 30 -- U.S. Patent and Trademark Office has published Mycotech Pharma As patent application for Antiviral Fungal Extracts. The invention was developed by Schmidt Ralf and Fiebich Bernd. The patent application number is US202319106961 20230721. The patent publication number is US20260083788 (A1). International..

U.S. Patent and Trademark Office Publishes Tummalapally Vijaykanth Patent Application for Formulation for Improved Brain Function

Pharmaceutical

| Mon 30 Mar 2026

Alexandria, March 30 -- U.S. Patent and Trademark Office has published Tummalapally Vijaykanth patent application for Formulation for Improved Brain Function. The patent application number is US202418894125 20240924. The patent publication number is US20260083784 (A1). International Patent Classification codes are A61K31/452..

Epizon Pharma Inc Files United States Patent Application for Pegylated Menaquinol Compositions and Methods of Treatment

Pharmaceutical

| Mon 30 Mar 2026

Alexandria, March 30 -- Epizon Pharma Inc has filed a patent application for Pegylated Menaquinol Compositions and Methods of Treatment. This invention was developed by Nguyen Sam L and Rudey John M. The patent application number is US202519409943 20251205. The patent publication number is US20260083773 (A1). International Pa..

Ambati Jayakrishna, Huang Peirong, Ambati Kameshwari, Univesity Of Virginia Patent Foundation and Univesity Of Virginia Submit Patent Application for Inflammasome Inhibition for Ne..

Pharmaceutical

| Mon 30 Mar 2026

Alexandria, March 30 -- Ambati Jayakrishna, Huang Peirong, Ambati Kameshwari, Univesity Of Virginia Patent Foundation and Univesity Of Virginia have submitted a patent application for Inflammasome Inhibition for Neuroprotection. Ambati Jayakrishna, Huang Peirong and Ambati Kameshwari developed the invention. The patent applic..

U.S. Patent and Trademark Office Publishes Qualia Life Sciences LLC Patent Application for Compositions for Supporting, Optimizing and/or Improving Nad+ Concentrations and Related ..

Pharmaceutical

| Mon 30 Mar 2026

Alexandria, March 30 -- U.S. Patent and Trademark Office has published Qualia Life Sciences LLC patent application for Compositions for Supporting, Optimizing And/or Improving Nad+ Concentrations and Related Methods. The invention was developed by Kelly Gregory. The patent application number is US202418891204 20240920. The pa..

Public University Corporation Nagoya City University Files United States Patent Application for Pharmaceutical Composition for Treating Brain Disease, Neuronal Migration Promoter, ..

Pharmaceutical

| Mon 30 Mar 2026

Alexandria, March 30 -- Public University Corporation Nagoya City University has filed a patent application for Pharmaceutical Composition for Treating Brain Disease, Neuronal Migration Promoter, and Use Thereof. This invention was developed by Sawamoto Kazunobu and Matsumoto Mami. The patent application number is US202319110..

Riconpharma LLC Seeks Patent for Stable Liquid Bortezomib Formulations

Pharmaceutical

| Mon 30 Mar 2026

Alexandria, March 30 -- Riconpharma LLC has sought patent for Stable Liquid Bortezomib Formulations. This invention was developed by Gande Mukteeshwar, Billa Praveen Reddy, Garikipati Svb Janardhan, Raichur Vinay Sudhindra and Thota Vijaya Kumar. The patent application number is US202519341758 20250926. The patent publication..

Harmony Biosciences Management Submits Patent Application for Treatment of SYNGAP1 Encephalopathy

Pharmaceutical

| Mon 30 Mar 2026

Alexandria, March 30 -- Harmony Biosciences Management has submitted a patent application for Treatment of SYNGAP1 Encephalopathy. Sebree Terri, Messenheimer John and Gutterman Donna developed the invention. The patent application number is US202519403384 20251128. The patent publication number is US20260083758 (A1). Internat..

Fertin Pharma Submits United States Patent Application for Dosage Forms for Delivery of Self-emulsifying Drug Delivery Systems

Pharmaceutical

| Mon 30 Mar 2026

Alexandria, March 30 -- Fertin Pharma has submitted a patent application for Dosage Forms for Delivery of Self-emulsifying Drug Delivery Systems. This invention was developed by Jensen Sanne Skov, Nikolajsen Gitte Nykjær and Wahlqvist Benjamin Bugge. The patent application number is US202418891058 20240920. The patent publicat..

Fertin Pharma Files United States Patent Application for Capsules with Self-emulsifying Drug Delivery Systems

Pharmaceutical

| Mon 30 Mar 2026

Alexandria, March 30 -- Fertin Pharma has filed a patent application for Capsules with Self-emulsifying Drug Delivery Systems. This invention was developed by Jensen Sanne Skov, Nikolajsen Gitte Nykjær and Wahlqvist Benjamin Bugge. The patent application number is US202418891015 20240920. The patent publication number is US202..

U.S. Patent and Trademark Office Receives Neurocrine UK Ltd Patent Application for Testosterone Containing Pharmaceutical Composition

Pharmaceutical

| Mon 30 Mar 2026

Alexandria, March 30 -- U.S. Patent and Trademark Office has received Neurocrine UK Ltd patent application for Testosterone Containing Pharmaceutical Composition. Whitaker Martin, Porter John, Ross Richard, Jones Stewart and Cocks Elizabeth developed the invention. The patent application number is US202519407268 20251203. The..

ImmunoGen Submits Patent Application for Anti-CD123 Immunoconjugates for the Treatment of Acute Myeloid Leukemia

Pharmaceutical

| Mon 30 Mar 2026

Alexandria, March 30 -- ImmunoGen has submitted a patent application for Anti-CD123 Immunoconjugates for the Treatment of Acute Myeloid Leukemia. Zweidler-mckay Patrick developed the invention. The patent application number is US202519204211 20250509. The patent publication number is US20260083749 (A1). International Patent C..

U.S. Patent and Trademark Office Releases Harrow Patent Application for Reduced Dosing Regimens for Glaucoma Treatment

Pharmaceutical

| Mon 30 Mar 2026

Alexandria, March 30 -- U.S. Patent and Trademark Office has released Harrow patent application for Reduced Dosing Regimens for Glaucoma Treatment. This invention was developed by Saadeh Dennis Elias. The patent application number is US202519339566 20250925. The patent publication number is US20260083746 (A1). International P..

Azurity Pharmaceuticals Ireland Ltd Files United States Patent Application for Lamotrigine Salts, Co-crystals, and Compositions

Pharmaceutical

| Mon 30 Mar 2026

Alexandria, March 30 -- Azurity Pharmaceuticals Ireland Ltd has filed a patent application for Lamotrigine Salts, Co-crystals, and Compositions. This invention was developed by Hunt Jordan R, Mosher Gerold, Jain Paras P and Lakshmipathula Krishna Mohan. The patent application number is US202519053770 20250214. The patent publ..

Georgia Tech Research Corporation Seeks Patent for Methods to Strengthen Visual Pathways

Pharmaceutical

| Mon 30 Mar 2026

Alexandria, March 30 -- Georgia Tech Research Corporation has sought patent for Methods to Strengthen Visual Pathways. This invention was developed by Fong Ming-fai and Lamprecht Robert D. The patent application number is US202519341461 20250926. The patent publication number is US20260083744 (A1). International Patent Classi..

Cerevel Therapeutics LLC Applies for Patent on Use of Tavapadon in Treating Parkinson's Disease

Pharmaceutical

| Mon 30 Mar 2026

Alexandria, March 30 -- Cerevel Therapeutics LLC has applied United States patent for Use of Tavapadon in Treating Parkinson's Disease. Duvvuri Sridhar developed it. The patent application number is US202519337808 20250923. The patent publication number is US20260083740 (A1). International Patent Classification codes are A61K..

Veradermics Incorporated Files United States Patent Application for Compositions and Methods of Use for Modified Release Minoxidil

Pharmaceutical

| Mon 30 Mar 2026

Alexandria, March 30 -- Veradermics Incorporated has filed a patent application for Compositions and Methods of Use for Modified Release Minoxidil. This invention was developed by Waldman Reid. The patent application number is US202519404931 20251201. The patent publication number is US20260083738 (A1). International Patent C..

Veradermics Incorporated Submits United States Patent Application for Compositions and Methods of Use for Modified Release Minoxidil

Pharmaceutical

| Mon 30 Mar 2026

Alexandria, March 30 -- Veradermics Incorporated has submitted a patent application for Compositions and Methods of Use for Modified Release Minoxidil. This invention was developed by Waldman Reid. The patent application number is US202519402798 20251126. The patent publication number is US20260083737 (A1). International Pate..

Boehringer Ingelheim International Submits United States Patent Application for Ghrelin O-acyl Transferase (GOAT) Inhibitors for Use in the Treatment of Substance Use Disorder in P..

Pharmaceutical

| Mon 30 Mar 2026

Alexandria, March 30 -- Boehringer Ingelheim International has submitted a patent application for Ghrelin O-acyl Transferase (GOAT) Inhibitors for Use in the Treatment of Substance Use Disorder in Patients with High Impulsivity. This invention was developed by Just Stefan, Cruces Solis Hugo, Du Hoffmann Johann Faustus, Dwyer Jen..

Intas Pharmaceuticals Submits United States Patent Application for Upadacitinib Formulation

Pharmaceutical

| Mon 30 Mar 2026

Alexandria, March 30 -- Intas Pharmaceuticals has submitted a patent application for Upadacitinib Formulation. This invention was developed by Patil Rahul Sudhakar, Patel Sandip Kumar Manubhai, Jamloki Ashutosh and Sehgal Ashish. The patent application number is US202319109053 20230906. The patent publication number is US202600..

IDEAYA Biosciences Submits Patent Application for Methods of Treating Uveal Melanoma with a PKC Inhibitor

Pharmaceutical

| Mon 30 Mar 2026

Alexandria, March 30 -- IDEAYA Biosciences has submitted a patent application for Methods of Treating Uveal Melanoma with a PKC Inhibitor. Maurer Matthew Anthony, O'quigley Michael Gabriel and Hambleton Julie developed the invention. The patent application number is US202319106906 20230825. The patent publication number is US..

U.S. Patent and Trademark Office Receives Baradaina LLC Patent Application for Methods of Treating Eye Disorders

Pharmaceutical

| Mon 30 Mar 2026

Alexandria, March 30 -- U.S. Patent and Trademark Office has received Baradaina LLC patent application for Methods of Treating Eye Disorders. Michael John C developed the invention. The patent application number is US202519200081 20250506. The patent publication number is US20260083730 (A1). International Patent Classificatio..

Ohio State Innovatiion Found and University of Kansas Apply for Patent on Compounds for Treating Infections with Parasitic Protozoa

Pharmaceutical

| Mon 30 Mar 2026

Alexandria, March 30 -- Ohio State Innovatiion Found and University of Kansas have applied United States patent for Compounds for Treating Infections with Parasitic Protozoa. Werbovetz Karl, Sharma Pankaj, La Rosa Chris, Wang Zhuo, Jin Yiru and Feng Mei developed it. The patent application number is US202319111246 20230918. T..

Boehringer Ingelheim International Submits United States Patent Application for Pharmaceutical Formulations of Nintedanib for Intraocular Use

Pharmaceutical

| Mon 30 Mar 2026

Alexandria, March 30 -- Boehringer Ingelheim International has submitted a patent application for Pharmaceutical Formulations of Nintedanib for Intraocular Use. This invention was developed by Ashton Paul, Chen Jianbing, Colbatzky Florian Andreas, Guo Hong, Luo Laibin and Schaefer Kerstin Julia. The patent application number is..

Astrizi Bio Inc Submits United States Patent Application for Piperidine Urea Derivatives for Obesity Therapy

Pharmaceutical

| Mon 30 Mar 2026

Alexandria, March 30 -- Astrizi Bio Inc has submitted a patent application for Piperidine Urea Derivatives for Obesity Therapy. This invention was developed by Khanna Ish, Pillarisetti Sivaram, Malkmus Hans Marcus and Kortschak Kathrin Christin. The patent application number is US202519338129 20250924. The patent publication ..

U.S. Patent and Trademark Office Releases The Childrens Mercy Hospital Patent Application for R-trihexyphenidyl for Treatment of Movement Disorders

Pharmaceutical

| Mon 30 Mar 2026

Alexandria, March 30 -- U.S. Patent and Trademark Office has released The Childrens Mercy Hospital patent application for R-trihexyphenidyl for Treatment of Movement Disorders. This invention was developed by Gelineau-morel Rose, Leeder James Steven and Toren Paul C. The patent application number is US202319111178 20230913. T..

Amorepacific Seeks Patent for Composition for Enhancing Immunity Containing Amide-based Compound

Pharmaceutical

| Mon 30 Mar 2026

Alexandria, March 30 -- Amorepacific has sought patent for Composition for Enhancing Immunity Containing Amide-based Compound. This invention was developed by Choi Eun Jeong, Jang Geunhyuk, Choi Hyunjung, Kim Hyoung June, Park Wonseok, Baek Heungsoo and You Jaewon. The patent application number is US202519335570 20250922. The..

Jnana Therapeutics Submits United States Patent Application for Dosing Regimen for Treating PKU with a Piperidine Inhibitor of SLC6A19 Function

Pharmaceutical

| Mon 30 Mar 2026

Alexandria, March 30 -- Jnana Therapeutics has submitted a patent application for Dosing Regimen for Treating PKU with a Piperidine Inhibitor of SLC6A19 Function. This invention was developed by Throup John Peter and Blanchette Heather Smith. The patent application number is US202319111597 20230825. The patent publication num..

1 to 100 of 1768 Items Next >>

Home
|
About Us
|
Privacy Policy
|
Support
|
Products
|
Careers
|
Contact Us

© Copyright 2015. All Right Reserved.

Email selected articles